GENET archive
[Index][Thread]
4-Patents: US court revives Bayer case against Monsanto on Bt corn
- To: GENET-news@genet-info.org
- Subject: 4-Patents: US court revives Bayer case against Monsanto on Bt corn
- From: coordination@genet-info.org
- Date: Wed, 7 Apr 2004 11:58:33 +0200
- Content-Transfer-Encoding: 8bit
- Content-Type: text/plain; charset=ISO-8859-1
- List-Help: <mailto:genet-news-request@genet-info.org?subject=help>
- List-Post: <mailto:genet-news@genet-info.org>
- List-Subscribe: <mailto:genet-news-request@genet-info.org?subject=subscribe>
- List-Unsubscribe: <mailto:genet-news-request@genet-info.org?subject=unsubscribe>
- Old-Return-Path: <coordination@genet-info.org>
- Resent-From: genet-news@genet-info.org
- User-Agent: Internet Messaging Program (IMP) 3.1-cvs
------------------------------- GENET-news -------------------------------
TITLE: US court revives Bayer case against Monsanto
SOURCE: Reuters, by Carey Gill
DATE: Apr 1, 2004
------------------- archive: http://www.genet-info.org -------------------
US court revives Bayer case against Monsanto
KANSAS CITY, Mo. - A U.S. appeals court this week revived Bayer
BioScience's patent claims in a legal dispute with rival Monsanto Co.
(MON.N: Quote, Profile, Research) over technology Monsanto uses in its
insect-resistant corn.
The ruling by the U.S. Court of Appeals for the Federal Circuit in
Washington D.C. overturned a lower court's issuance of a summary judgment
in favor of Monsanto, saying the issues needed to be decided through a
trial of the facts.
The four-year-old dispute between St. Louis, Missouri-based Monsanto and
the unit of Bayer AG (BAYG.DE: Quote, Profile, Research) of Germany
involves four key patents and whether or not Monsanto has infringed on
those patents.
Bayer officials heralded the news Tuesday and said they hope to ultimately
force Monsanto to pay royalties based on both past and future sales of its
Bt corn.
"In essence the court really reversed all of the decisions of the district
court below and found entirely in favor of Bayer," said Philippe Dumont,
head of technology management for Bayer. "We have a high feeling of
vindication."
But Monsanto spokesman Bryan Hurley said the setback was minor.
"The court only decided that there are matters of fact that couldn't be
decided on summary judgment, and while we're disappointed ... we're poised
and ready to go to trial rapidly to obtain a final ruling that the patents
are invalid," Hurley said.
The case involves four patents covering technology that alters plant DNA
in a way that makes the plant engineer a bacterium that is toxic to
insects. The technology was developed and patented by a predecessor to
Bayer, but Monsanto has used similar methods in developing its popular
biotech Bt corn product.
Bayer BioScience is a business group of Bayer CropScience AG based in
Monheim, Germany, which is a unit of Bayer AG (BAYG.DE: Quote, Profile,
Research) .
The ruling by the appellate court comes nearly six months after Monsanto
and Bayer resolved several other patent disputes through cross-licensing
agreements.
It also follows the news in December that Bayer received an exclusive
license for agrobacterium-transformation technology after a 20-year battle
with Monsanto.
--
GENET
European NGO Network on Genetic Engineering
Hartmut MEYER (Mr)
Kleine Wiese 6
D - 38116 Braunschweig
Germany
P: +49-531-5168746
F: +49-531-5168747
M: +49-162-1054755
E: coordination(at)genet-info.org
W: <http://www.genet-info.org>
-----------------------------
GENET-news mailing list
-----------------------------